EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 299 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,000 | -21.1% | 299 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | -45.7% | 299 | -19.0% | 0.00% | – |
| Q1 2021 | $35,000 | +29.6% | 369 | +23.4% | 0.00% | – |
| Q4 2020 | $27,000 | -12.9% | 299 | 0.0% | 0.00% | – |
| Q3 2020 | $31,000 | +29.2% | 299 | 0.0% | 0.00% | – |
| Q2 2020 | $24,000 | +1100.0% | 299 | +806.1% | 0.00% | – |
| Q1 2019 | $2,000 | -91.7% | 33 | -92.0% | 0.00% | – |
| Q4 2018 | $24,000 | +84.6% | 410 | -0.5% | 0.00% | – |
| Q3 2016 | $13,000 | +225.0% | 412 | +255.2% | 0.00% | – |
| Q1 2016 | $4,000 | -99.8% | 116 | -99.7% | 0.00% | -100.0% |
| Q4 2015 | $1,785,000 | +40.4% | 44,604 | 0.0% | 0.01% | +42.9% |
| Q3 2015 | $1,271,000 | +1296.7% | 44,604 | +837.8% | 0.01% | +600.0% |
| Q3 2013 | $91,000 | – | 4,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
| Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
| AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
| Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
| Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
| SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
| EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
| PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |